Christos Chouaid

65PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jul 14, 2026
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

|Mar 27, 2026
Real-World Treatment Patterns and Survival in Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe.

Winson Y Cheung, Adam Lee, Helena Bote de Cabo

|Dec 15, 2025
Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration.

Pasquale F Innominato, Thierry Landré, Abdoulaye Karaboué

|Nov 26, 2025
Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.

Hervé Bischoff, Sébastien Gendarme, Laura Somme

|Nov 05, 2025
The LEAP Study: A Multicenter Biospecimen and Imaging Resource for Lung Cancer Screening.

Jennifer B Dennison, Sebastien Gendarme, Nicole M Kettner

|Aug 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study).

Renaud Descourt, Florian Guisier, Maurice Pérol

Pageof 11

Frequent Collaborators

8 joint publications

Florian Guisier

5 joint publications

Jean-Bernard Auliac

5 joint publications

Thierry Landre

4 joint publications

Jean-Baptiste Assié